Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

0.378

+0.001 (0.16%)

At close: Mar 6, 2026, 4:00 PM EST

0.396

+0.018 (4.87%)

After-hours: Mar 6, 2026, 7:53 PM EST

Sangamo Therapeutics Market Cap

Sangamo Therapeutics has a market cap or net worth of $140.31 million as of March 6, 2026. Its market cap has decreased by -39.96% in one year.

Market Cap

140.31M

Enterprise Value

136.12M

1-Year Change

-39.96%

Ranking

#4053

Market Cap Chart

Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $140.31M, a decrease of -55.33%. That is a compound annual growth rate of -3.06%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	127.20M	-9.98%
Dec 31, 2025	141.30M	-33.60%
Dec 31, 2024	212.80M	120.98%
Dec 29, 2023	96.30M	-81.29%
Dec 30, 2022	514.60M	-52.90%
Dec 31, 2021	1.09B	-50.50%
Dec 31, 2020	2.21B	127.45%
Dec 31, 2019	970.40M	-17.20%
Dec 31, 2018	1.17B	-15.45%
Dec 29, 2017	1.39B	543.50%
Dec 30, 2016	215.40M	-66.32%
Dec 31, 2015	639.50M	-38.53%
Dec 31, 2014	1.04B	21.20%
Dec 31, 2013	858.40M	169.51%
Dec 31, 2012	318.50M	113.76%
Dec 30, 2011	149.00M	-50.38%
Dec 31, 2010	300.30M	12.98%
Dec 31, 2009	265.80M	86.40%
Dec 31, 2008	142.60M	-72.71%
Dec 31, 2007	522.60M	133.30%
Dec 29, 2006	224.00M	118.75%
Dec 30, 2005	102.40M	-32.23%
Dec 31, 2004	151.10M	11.35%
Dec 31, 2003	135.70M	83.13%
Dec 31, 2002	74.10M	-67.54%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Innate Pharma	151.10M
Zentalis Pharmaceuticals	148.60M
Corbus Pharmaceuticals Holdings	148.41M
Unicycive Therapeutics	141.84M
MacroGenics	141.07M
Artiva Biotherapeutics	140.89M
Connect Biopharma Holdings	138.64M
Adagene	133.85M

Market Cap Rankings